Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus

Male Antifungal Agents virulence factors Secondary Metabolism Microbial Sensitivity Tests Microbiology Polymorphism, Single Nucleotide Article superinfection secondary infection pathogenicity Humans Metabolomics Aged Virulence SARS-CoV-2 Aspergillus fumigatus COVID-19 Genomics acute respiratory distress syndrome Middle Aged coinfection QR1-502 3. Good health Aspergillus Phenotype Mutation Female Pulmonary Aspergillosis Research Article
DOI: 10.1128/spectrum.00010-21 Publication Date: 2021-06-13T22:42:19Z
ABSTRACT
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), has already killed millions of people. COVID-19 patient outcome can be further complicated by secondary infections, such as COVID-19-associated pulmonary aspergillosis (CAPA).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (112)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....